These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 4172470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Nutritional requirement of cancer cells: inhibition of the growth of cancer cells by L-asparaginase].
    Honjo T, Hayaishi O.
    Tanpakushitsu Kakusan Koso; 1970 Apr; 15(5):515-23. PubMed ID: 4913828
    [No Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of L-asparaginase. Introduction.
    Burchenal JH, Karnofsky DA.
    Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
    [No Abstract] [Full Text] [Related]

  • 4. L-asparagine and leukemia.
    Old LJ, Boyse EA, Campbell HA.
    Sci Am; 1968 Aug; 219(2):34-40. PubMed ID: 4874838
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical significance of L-asparaginase].
    Benkö S.
    Orv Hetil; 1969 Aug 31; 110(35):2019-23. PubMed ID: 4900161
    [No Abstract] [Full Text] [Related]

  • 7. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
    Wade HE.
    J Gen Microbiol; 1971 Mar 31; 65(3):x-xi. PubMed ID: 4997395
    [No Abstract] [Full Text] [Related]

  • 8. [Asparaginase].
    Boiron M, Jacquillat C, Weil M, Tanzer J, Bernard J.
    Presse Med (1893); 1968 Nov 16; 76(44):2099-101. PubMed ID: 4882819
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.
    Yoshimoto T, Nishimura H, Saito Y, Sakurai K, Kamisaki Y, Wada H, Sako M, Tsujino G, Inada Y.
    Jpn J Cancer Res; 1986 Dec 16; 77(12):1264-70. PubMed ID: 3102431
    [Abstract] [Full Text] [Related]

  • 11. [L-asparaginase: A new principle in the chemotherapy of malignant neoplasms].
    Oettgen HF.
    Blut; 1969 Sep 16; 19(6):351-6. PubMed ID: 4896647
    [No Abstract] [Full Text] [Related]

  • 12. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J, Schmid FA, Old LJ, Stockert E.
    Cancer Biochem Biophys; 1976 May 16; 1(4):175-8. PubMed ID: 788892
    [Abstract] [Full Text] [Related]

  • 13. [Asparaginase and acute leukemia].
    Benbenishti D.
    Harefuah; 1971 Feb 01; 80(3):156. PubMed ID: 5099261
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biocmical and pharmacologic effects of L-asparaginase in man.
    Haskell CM, Canellos GP, Cooney DA, Hansen HH.
    J Lab Clin Med; 1970 May 01; 75(5):763-70. PubMed ID: 4909251
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
    Haskell CM, Canellos GP, Cooney DA, Hardesty CT.
    Cancer Chemother Rep; 1972 Oct 01; 56(5):611-4. PubMed ID: 4569055
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive action of L-asparaginase.
    Alexander P.
    Proc R Soc Med; 1972 Mar 01; 65(3):265-6. PubMed ID: 5083314
    [No Abstract] [Full Text] [Related]

  • 18. Glycine inhibition of asparaginase.
    Ryan WL, Sornson HC.
    Science; 1970 Mar 13; 167(3924):1512-3. PubMed ID: 4906004
    [Abstract] [Full Text] [Related]

  • 19. [Antineoplastic activity of various bacterial enzyme preparations].
    Pszczólska G, Krzemiński Z.
    Pol Tyg Lek; 1969 Oct 27; 24(43):1660-3. PubMed ID: 4901697
    [No Abstract] [Full Text] [Related]

  • 20. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)].
    Nikolaev AIa.
    Probl Gematol Pereliv Krovi; 1969 Jul 27; 14(7):51-60. PubMed ID: 4903458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.